Associated Papers
Cardiomyopathy-associated and basic residue mutations in myopalladin alter actin binding, bundling, and structural stability.
Arachchige AR et al.
Protein Science : a Publication of the Protein Society, 2026
Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy.
Bonaventura J et al.
Journal of the American Heart Association, 2024
38757491 (PubMed )
Supplement: JAH3-13-e033565-s001.pdf
The Role of Z-disc Proteins in Myopathy and Cardiomyopathy.
Wadmore K et al.
International Journal of Molecular Sciences, 2021
The GenomeAsia 100K Project enables genetic discoveries across Asia.
Unknown Author
Nature, 2019
31802016 (PubMed )
Supplement: 41586_2019_1793_MOESM3_ESM.xlsx › S4b_-_Disease_Var
Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.
Walsh R et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2017
27532257 (PubMed )
Supplement: gim201690x1.zip › Supplementary_Tables_resubmit.xlsx › Table_S12
Analyses of more than 60,000 exomes questions the role of numerous genes previously associated with dilated cardiomyopathy.
Nouhravesh N et al.
Molecular Genetics & Genomic Medicine, 2016
Novel mutations in the sarcomeric protein myopalladin in patients with dilated cardiomyopathy.
Meyer T et al.
European Journal of Human Genetics : Ejhg, 2013
Evaluating pathogenicity of rare variants from dilated cardiomyopathy in the exome era.
Norton N et al.
Circulation. Cardiovascular Genetics, 2012
Cytoplasmic Ig-domain proteins: cytoskeletal regulators with a role in human disease.
Otey CA et al.
Cell Motility and the Cytoskeleton, 2009
Mutations in the Z-band protein myopalladin gene and idiopathic dilated cardiomyopathy.
Duboscq-Bidot L et al.
Cardiovascular Research, 2008
Select a paper to view details